ERIK LONG: Open Payments
NPI 1609834621 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 31 payments from 11 companies in 2025. Trend: 2023 $140 · 2024 $532 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $278 |
| Insulet Corporation | 1 | $65 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $42 |
| Corcept Therapeutics | 2 | $37 |
| Lundbeck LLC | 2 | $37 |
| Medtronic, Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Viatris Specialty LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: VRAYLAR, Omnipod, REXULTI, QULIPTA, AUSTEDO XR, Korlym, INCEPTIV, MAVYRET.
Industry payments across ID — which companies pay providers there.
